Fulminant acneiform eruptions after administration of dovitinib in a patient with renal cell carcinoma.
Chang Gung Memorial Hospital, Taipei, Taiwan.
Ya-Wen
YW
Hsiao
Yung-Chang
YC
Lin
Rosaline Chung-Yee
RC
Hui
Chih-Hsun
CH
Yang
D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D001706:Biopsy; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000201:enzymology / Q000556:secondary; D003879:Dermatologic Agents / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D057915:Drug Substitution; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000556:secondary; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D016896:Treatment Outcome
D003879:Dermatologic Agents; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases